ESR1 and neoplasm: The analysis was then performed between ER-positive/miR-18a/low (n = 370), ER-positive/miR-18a/high (n = 377), ER-negative/miR-18a/low (n = 105) and ER-negative/miR-18a/high (n = 106) tumour samples (Figure 5A).